These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


127 related items for PubMed ID: 12365660

  • 21. [Rubella epidemiology in Italy in years 1998-2004].
    Giambi C, Rota MC, Bella A, Filia A, Gabutti G, Guido M, De Donno A, Ciofi degli Atti ML.
    Ann Ig; 2007; 19(2):93-102. PubMed ID: 17547214
    [Abstract] [Full Text] [Related]

  • 22. Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
    Vesikari T, Baer M, Willems P.
    Pediatr Infect Dis J; 2007 Feb; 26(2):153-8. PubMed ID: 17259879
    [Abstract] [Full Text] [Related]

  • 23. Prospective evaluation of pregnant women vaccinated against rubella in southern Brazil.
    Minussi L, Mohrdieck R, Bercini M, Ranieri T, Sanseverino MT, Momino W, Callegari-Jacques SM, Schuler-Faccini L.
    Reprod Toxicol; 2008 Jan; 25(1):120-3. PubMed ID: 17977696
    [Abstract] [Full Text] [Related]

  • 24. Rubella and congenital rubella syndrome in Japan: epidemiological problems.
    Terada K.
    Jpn J Infect Dis; 2003 Jun; 56(3):81-7. PubMed ID: 12944671
    [Abstract] [Full Text] [Related]

  • 25. Congenital hearing impairment associated with rubella: lessons from Bangladesh.
    Rahman MM, Khan AM, Hafiz MM, Ronny FM, Ara S, Chowdhury SK, Nazir SS, Khan WI.
    Southeast Asian J Trop Med Public Health; 2002 Dec; 33(4):811-7. PubMed ID: 12757231
    [Abstract] [Full Text] [Related]

  • 26. Congenital rubella syndrome: progress and future challenges.
    Morice A, Ulloa-Gutierrez R, Avila-Agüero ML.
    Expert Rev Vaccines; 2009 Mar; 8(3):323-31. PubMed ID: 19249974
    [Abstract] [Full Text] [Related]

  • 27. [Rubella epidemic in the Netherlands, 2004/'05: awareness of congenital rubella syndrome required].
    Hahné SJ, Abbink F, van Binnendijk RS, Ruijs WL, van Steenbergen JE, de Melker HE.
    Ned Tijdschr Geneeskd; 2005 May 21; 149(21):1174-8. PubMed ID: 15940923
    [Abstract] [Full Text] [Related]

  • 28. Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.
    France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R, Vaccine Safety Datalink Team.
    Pediatrics; 2008 Mar 21; 121(3):e687-92. PubMed ID: 18310189
    [Abstract] [Full Text] [Related]

  • 29. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
    Lieberman JM, Williams WR, Miller JM, Black S, Shinefield H, Henderson F, Marchant CD, Werzberger A, Halperin S, Hartzel J, Klopfer S, Schödel F, Kuter BJ, Consistency Lot Study Group for ProQuad.
    Pediatr Infect Dis J; 2006 Jul 21; 25(7):615-22. PubMed ID: 16804432
    [Abstract] [Full Text] [Related]

  • 30. Brief report: Imported case of congenital rubella syndrome--New Hampshire, 2005.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2005 Nov 18; 54(45):1160-1. PubMed ID: 16323362
    [Abstract] [Full Text] [Related]

  • 31. Congenital rubella syndrome: ophthalmic manifestations and associated systemic disorders.
    Givens KT, Lee DA, Jones T, Ilstrup DM.
    Br J Ophthalmol; 1993 Jun 18; 77(6):358-63. PubMed ID: 8318483
    [Abstract] [Full Text] [Related]

  • 32. [Chronic exanthema in a child with congenital rubella].
    Lasek-Duriez A, Hubiche T, Aladjidi N, Lamireau T, Taïeb A, Léauté-Labrèze C.
    Ann Dermatol Venereol; 2008 Mar 18; 135(3):222-4. PubMed ID: 18374856
    [Abstract] [Full Text] [Related]

  • 33. [The present situation and limitation of antibody assays for diagnosis of rubella virus infection in pregnant women].
    Katow S, Umino Y.
    Rinsho Byori; 2003 Mar 18; 51(3):263-7. PubMed ID: 12708000
    [Abstract] [Full Text] [Related]

  • 34. [Neonatal cutaneous hematopoiesis disclosing congenital rubella].
    Penouil MH, Bressieux JM, Mehaut S, Hopfner C.
    Ann Dermatol Venereol; 1996 Mar 18; 123(5):334-6. PubMed ID: 8761088
    [Abstract] [Full Text] [Related]

  • 35. Progress in Italy in control and elimination of measles and congenital rubella.
    Bonanni P, Bechini A, Boccalini S, Peruzzi M, Tiscione E, Boncompagni G, Mannelli F, Salmaso S, Filia A, Ciofi degli Atti M.
    Vaccine; 2007 Apr 20; 25(16):3105-10. PubMed ID: 17306425
    [Abstract] [Full Text] [Related]

  • 36. Measles and rubella in the World Health Organization European region: diversity creates challenges.
    Spika JS, Wassilak S, Pebody R, Lipskaya G, Deshevoi S, Guris D, Emiroglu N.
    J Infect Dis; 2003 May 15; 187 Suppl 1():S191-7. PubMed ID: 12721913
    [Abstract] [Full Text] [Related]

  • 37. [Manifestation of congenital rubella syndrome: clinical and epidemiologic aspects].
    Lahbil D, Souldi L, Rais L, Lamari H, El Kettani A, Zaghloul K.
    Bull Soc Belge Ophtalmol; 2007 May 15; (303):13-20. PubMed ID: 17894282
    [Abstract] [Full Text] [Related]

  • 38. The epidemiological profile of rubella and congenital rubella syndrome in the United States, 1998-2004: the evidence for absence of endemic transmission.
    Reef SE, Redd SB, Abernathy E, Zimmerman L, Icenogle JP.
    Clin Infect Dis; 2006 Nov 01; 43 Suppl 3():S126-32. PubMed ID: 16998771
    [Abstract] [Full Text] [Related]

  • 39. Fetal risk associated with rubella vaccination during pregnancy.
    Badilla X, Morice A, Avila-Aguero ML, Saenz E, Cerda I, Reef S, Castillo-Solórzano C.
    Pediatr Infect Dis J; 2007 Sep 01; 26(9):830-5. PubMed ID: 17721380
    [Abstract] [Full Text] [Related]

  • 40. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E, Zakarian R, Bennett A, Meng L, McLean-Heywood D.
    Pediatrics; 2006 Jul 01; 118(1):e139-50. PubMed ID: 16818529
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.